Calcium-evoked dendritic exocytosis (CEDE), demonstrated in cultured hippocampal neurons, is a novel mechanism that could play a role in synaptic plasticity. A number of forms of neuronal plasticity are thought to be mediated by calcium/ calmodulin-dependent protein kinase II (CaMKII). Here, we investigate the role of CaMKII in CEDE. We find that the developmental time course of CEDE parallels the expression of ␣CaMKII, a dominant subunit of CaMKII. An inhibitor of this enzyme, KN-62, blocks CEDE. Furthermore, 7 d in vitro neurons (which normally do not express ␣CaMKII nor show CEDE) can undergo CEDE when infected with a recombinant virus producing ␣CaMKII. Expression of a constitutively active CaMKII produces dendritic exocytosis in the absence of calcium stimulus, and this exocytosis is blocked by nocodazole, an inhibitor of microtubule polymerization that also blocks CEDE. These results indicate that CEDE is mediated by the activation of CaMKII, consistent with the view that CEDE plays a role in synaptic plasticity.
receptor contribution to synaptic transmission at resting membrane potential is sparse because of its voltage-dependent properties (Hestrin et al., 1990) . In this LTP model some synapses have both AMPA and NMDA receptors, whereas other synapses have only NMDA receptors. These latter synapses are functionally silent, because at normal resting potential the transmitter release does not give any postsynaptic response. During LTP induction AMPA receptors could be inserted into the membrane of both kinds of synapses. This would transform silent synapses into functional ones and increase the response amplitude at those synapses that were functional before LTP. In this model the increase in AMPA receptors at synapses then could be responsible for the enhanced transmission. Replenishment of existing receptors, in the absence of LTP-inducing stimuli, could allow enhanced transmission to persist in the face of protein turnover.
However, little is known about the mechanisms that govern the targeting, clustering, and insertion of receptors into the postsynaptic membrane. At the best-characterized synapse, neuromuscular junction, acetylcholine receptor formation is an intrinsic property of the postsynaptic cell, whereas the recruitment of the receptor microclusters to form large postsynaptic aggregates is triggered by presynaptic events (Hall and Sanes, 1993) . Hence, it is possible that in central neurons the receptors are confined in intracellular membranous compartments throughout a dendritic tree and are delivered selectively to postsynaptic sites where epigenetic factors like synaptic activity may induce their incorporation into the membrane. Recent electron microscopy studies on central excitatory synapses report the presence of intracellular membranous compartments and vesicles inside dendritic spines (Spacek and Harris, 1997) as well as intracellular AMPA receptors (Petralia and Wenthold, 1992; Rubio and Wenthold, 1997) . Increased ␣CaMKII selectively increases AMPA responses (Wu et al., 1996; Shirke and Malinow, 1997) and decreases silent synapses (Wu et al., 1996) . Furthermore, a recent study indicated that LTP generation is blocked by inhibitors of regulated postsyn-
Immunoc ytochemistr y
Cultures (3-15 d in vitro, DIV) were fixed in 4% paraformaldehyde in 0.1 M PBS containing 0.12 M sucrose, for 20 min at ϩ4°C, and immediately permeabilized with 0.3% Triton X-100 in PBS for 5 min at room temperature. They were incubated in blocking solution (10% horse serum, 1% goat-serum, and 0.1% Triton X-100 in PBS) for 1 hr at room temperature and then immunostained overnight at ϩ4°C with the primary ␣C aM K II-specific monoclonal antibody (10 g /ml; Boehringer Mannheim, Indianapolis, I N). After the washout of the primary antibody with blocking solution, the cultures were exposed to secondary FI TCconjugated goat anti-mouse antibody (30.8 g /ml; C appel, West Chester, PA) for 2 hr at room temperature. Immunoreactivity (IR) was analyzed immediately after the secondary antibody was washed away [FI TC filter, Z eiss Axioskop (Oberkochen, Germany), 50 W mercury lamp].
Labeling neurons with FM1-43
Cultures were exposed for 16 -36 hr to 1.5 M FM1-43 at 35.5°C before being transferred to the microscope stage. Cultures were rinsed with 0.1% DMSO for 1 min and maintained in constantly perf using bath solution for 1 hr. The bath solution [containing (in mM) 119 NaC l, 2.5 KC l, 1.3 MgC l 2 , 2.5 CaCl 2 , 1 NaH 2 PO 4 , 26.2 NaHC O 3 , and 11 glucose] also contained 1 M tetrodotoxin to abolish action potentials.
Calcium-evoked dendritic exocytosis
After overnight loading with 1.5 M FM1-43, the cultures were transferred to the microscope stage and maintained in constantly perf using bath solution for 1 hr. C alcium ionophore A23187 (1 M) was applied directly onto the coverslip for 1 min. Fluorescence was monitored for 30 min before and 30 min after A23187 application, at 15 min intervals. An additional image was taken ϳ5 min after ionophore application. All images in a given experiment were taken with the same exposure time (100 -500 msec, chosen so that the fluorescent signal did not saturate the camera detection limit).
K N-62 treatment. Mature cultures (Ͼ9 DIV) were loaded overnight with 1.5 M FM1-43 and then exposed to 0.5 M or 5 M K N-62 for 1.5 hr (during the 1 hr initial wash period and 30 min after A23187 application). K N-62-containing bath solution was replaced with fresh bath solution. Thirty minutes later A23187 was reapplied, and its effect was monitored for 20 min.
Infections
Vaccinia virus was constructed and purified as described (Pettit et al., 1995) . Viruses contain a strong synthetic promoter driving the expression of either ␤-galactosidase alone (␤GALV V) or the protein of interest␣CaMKII (fCaMKIIVV) or ␣C aM K II(1-290) (tC aM K IIV V). In the viruses expressing C aM K II, a second (ϳ40 times weaker) promoter drives the expression of ␤-galactosidase. Cultures were infected at 3-5 multiplicity of infection (MOIs) for 6 hr at 35.5°C after a 12 hr exposure to FM1-43 (fC aM K IIV V, total exposure to FM1-43 was 18 hr) or at 5-10 MOIs for 12 hr at 35.5°C, along with the FM1-43 (tC aM K IIV V). More than 90% infection was confirmed by X-gal staining in ␤GALV V-, fC aM K IIV V-, and tC aM K IIV V-infected cells.
Nocodazole treatment. Mature cultures (Ͼ9 DIV), loaded overnight with 1.5 M FM1-43 and infected with the tC aM K IIV V, were exposed for 45 min to 2.5 g /ml nocodazole in the presence of 1.5 M FM1-43 at 35.5°C. E xperiments were performed as above.
Microscopy
Images were acquired with a computer-controlled cooled CCD camera (Photometrics, T ucson, AZ), using FI TC filters (peak at 450 nm) on a Z eiss Axioskop epifluorescence microscope (50 W mercury lamp), and processed with Photometrics-supplied software (PM IS).
Data analysis
For quantitative measurements of CEDE, several regions of interest (2-5) were placed on dendrites (locations chosen before post-treatment images were analyzed), and FM1-43 fluorescence was integrated. Background fluorescence, measured in regions next to the neurons, was subtracted. FM1-43 fluorescence values were normalized to the intensity observed immediately before A23187 application. Statistical analysis was done by one-way ANOVA.
RESULTS
Our studies of CEDE (Maletic-Savatic and Malinow, 1998) indicate that this process is regulated developmentally, because we observed it only in mature cultured hippocampal neurons. We sought to identify which factor or factors made neurons 9 DIV or older competent to show CEDE. We concentrated our efforts on one Ca 2ϩ -activated enzyme, CaMKII (Braun and Schulman, 1995) , which previously has been demonstrated to show developmentally regulated expression (Kelly and Vernon, 1985) . Using immunocytochemistry, we found that a major constituent of CaMKII, ␣CaMKII, had a similar developmental expression pattern to the onset of CEDE. In particular, in our culture conditions the expression level of ␣CaMKII in processes was very weak at 7 DIV and robust by 9 DIV (Fig. 1 A) . In addition, at 7 DIV ␣CaMKII was detected only as a homogeneous perinuclear staining, whereas from 9 DIV onward it accumulated as distinct, intensely stained patches in dendrites. As previously reported (Scholz et al., 1988; Tighilet et al., 1998) , the enzyme was not expressed in astrocytes, which form a supportive confluent monolayer of cells beneath hippocampal neurons. We performed a quantitative analysis of the ␣CaMKII expression in neuronal soma and processes (Fig. 1 B) . ␣CaMKII-IR in processes increased with the age of cultures, with a particularly large rise from 7 to 9 DIV. Similarly, we observed CEDE only in neurons older than 9 DIV (Maletic-Savatic and Malinow, 1998) .
To determine whether CaMKII activation is necessary for CEDE, we tested the effect of KN-62, an inhibitor of CaMKII (Tokumitsu et al., 1990) . Mature neurons were loaded overnight with FM1-43 and treated for 1 hr with 0.5 or 5 M KN-62. Calcium ionophore challenge produced no significant CEDE in the presence of 5 M KN-62 (3.1 Ϯ 1.5% of control CEDE, n ϭ 8; Fig. 2 A,B ) and 31.6 Ϯ 6.8% of control CEDE in the presence of 0.5 M KN-62 (n ϭ 3; Fig. 2 B) . On washout of the inhibitor, a subsequent calcium ionophore challenge produced robust exocytosis (Fig. 2) . These results indicate that CEDE requires CaMKII activity.
Is diminished CaMKII activity, as a consequence of the lack of ␣CaMKII, the critical component lacking in 7 DIV neurons, making them incompetent to display CEDE? We directly tested this hypothesis by introducing ␣CaMKII into neurons, using a recombinant vaccinia virus expression system (Pettit et al., 1994 (Pettit et al., , 1995 at an early developmental age when endogenous ␣CaMKII was not present. We determined conditions that allowed for the infection and expression of recombinant product in virtually all of the cells in a culture dish (Fig. 3A) . We visualized the expression pattern of a recombinant hemagglutinin epitope-tagged ␣CaMKII within a neuron (Fig. 3B) . Virally expressed recombinant ␣CaMKII was delivered to dendrites and showed a punctate staining pattern, similar to that seen for endogenous ␣CaMKII (see Fig. 1 A) .
As shown in Figure 4 A, 7 DIV neurons with no infection or infected with a virus producing only the control protein ␤-galactosidase showed no CEDE. However, 7 DIV neurons infected with a virus producing ␣CaMKII (fC aM K II; Figs. 3B, 4 A) after overnight FM1-43 loading showed CEDE that was comparable in magnitude to that seen with 9 DIV neurons in control conditions (Fig. 4 A) . Interestingly, 9 DIV neurons infected with a virus producing ␣CaMKII showed larger CEDE than control 9 DIV neurons (Fig. 4 B) , suggesting that the amount of ␣CaMKII protein is rate-limiting for CEDE in these neurons. Also, neurons Ͻ7 DIV showed little CEDE when infected with a virus-producing ␣CaMKII (Fig. 4 B) , suggesting that developmentally regulated factors other than ␣CaMKII also control CEDE.
To test if the activity of CaMKII is sufficient to produce dendritic exocytosis, we analyzed the effect of a truncated, constitutively active form of CaMKII (tCaMKII) that contains only the catalytic domain of the enzyme (Pettit et al., 1994) . The infection of neurons with a recombinant vaccinia virus producing tCaMKII (tCaMKIIVV) has been shown previously to increase CaMKII activity (Pettit et al., 1994) . We loaded mature neurons overnight with FM1-43 and infected them for 12 hr with tCaMKIIVV. Neurons that were not infected or infected with a virus producing the control protein (␤-galactosidase) showed little loss of dye during a 1 hr observation period (Fig. 5) . However, neurons infected with tCaMKIIVV showed a significant loss of FM1-43 (Fig. 5) . This indicates that constitutively active CaMKII can induce dendritic exocytosis in the absence of a calcium stimulus.
To determine possible downstream targets of CaMKII mediating dendritic exocytosis, we investigated the effects of nocodazole, an agent producing microtubule depolymerization (Goslin et al., 1989) . Nocodazole effectively blocked CEDE (MaleticSavatic and Malinow, 1998) . In addition, nocodazole blocked the exocytosis produced by tCaMKIIVV (Fig. 5) , indicating that intact microtubules are required for dendritic exocytosis.
DISCUSSION

CaMKII activity and CEDE
The principal findings of this study are that the activation of CaMKII is both necessary and can be sufficient to generate CEDE. Here we report four independent experimental approaches that support these findings: (1) the expression of ␣CaMKII, a major constituent of CaMKII, in dendritic processes of cultured hippocampal neurons parallels the developmental time course of CEDE; (2) an inhibitor of CaMKII, KN-62, prevents CEDE; (3) neurons 7 DIV that normally neither express ␣CaMKII nor show CEDE become competent to manifest CEDE when infected with a recombinant virus producing ␣CaMKII; and (4) neurons infected with a recombinant virus producing constitutively active CaMKII show dendritic exocytosis in the absence of a calcium stimulus. These results indicate that CaMKII activation mediates CEDE in these neurons. Therefore, these results further characterize CEDE and assign another function to CaMKII.
Our studies of ␣CaMKII immunoreactivity generally agree with earlier studies on the developmental expression of this subunit of CaMKII in cultured hippocampal neurons (Scholz et al., 1988) . Little ␣CaMKII immunoreactivity is seen before 9 DIV, at which point there is a fairly abrupt increase in expression, particularly in processes. A similar developmental increase was reported for the phosphorylation of synaptic junction proteins by endogenous CaMKII (Kelly et al., 1987) . In our cultures, synaptic responses appear ϳ7 DIV, becoming much more pronounced over the next few days (our unpublished results). It appears that, with such an expression pattern, ␣CaMKII is well poised to participate in synapse formation or maturation. Indeed, such a role has been proposed for CaMKII in the maturation of retinotectal synapses (Wu et al., 1996) .
Our studies of CaMKII expression indicate that this enzyme, or at least the ␣-subunit, dramatically increases developmentally at the same time as that when we detect CEDE. However, is the activity of CaMKII necessary for CEDE? To test this hypothesis, we blocked CaMKII activity with KN-62 (see Fig. 2) . These experiments showed a concentration-dependent block of CEDE by KN-62. Because this drug also blocks CaMKIV, with this experiment we cannot rule out the possibility that this enzyme is required for CEDE.
Possibly the most compelling results indicating a role for CaMK II in CEDE come from the experiments in which recombinant ␣CaMKII is expressed in 7 DIV neurons. At this point in development these neurons normally neither express ␣CaMKII nor show CEDE. However, the expression of recombinant ␣CaMKII renders these neurons competent to show CEDE. The expression of constitutively active C aM K II demonstrated that activity of this enzyme, in the absence of a calcium stimulus, is sufficient to trigger dendritic exocytosis.
CaM K II has been implicated in the regulation of presynaptic exocytosis, acting on actin binding of presynaptic vesicles (Ceccaldi et al., 1995) . C aM K II injected presynaptically in squid giant synapse facilitated transmitter release (L linás et al., 1991) . Additionally, the extracellular application of synthetic peptide inhibitors of C aM K II suppressed the phosphorylation of synapsin I at the C aM K II-specific site and decreased excitatory synaptic responses elicited in the CA1 hippocampal region (Waxham et al., 1993) . On the basis of these results C aM K II is postulated to play an essential role in the recruitment of presynaptic vesicles, possibly by freeing vesicles from an actin-bound pool. In addition, CaMKII has been implicated in the exocytosis of dense-core vesicles in PC12 cells (Schweitzer et al., 1995) . These experiments indicated that CaMKII action modulates a step between Ca 2ϩ influx and the fusion of dense-core vesicles in PC12 cells. In addition to its role in presynaptic function, CaMKII has been implicated in mediating cell membrane resealing via a vesicular exocytotic process (Steinhardt et al., 1994) .
Our results indicate that CaMKII acts also as a regulator of dendritic and postsynaptic exocytosis. What are the downstream targets of active CaMKII in dendrites? We find that depolymerization of microtubules prevents exocytosis produced by constitutive CaMKII activity, indicating that microtubule function is required in parallel or downstream of CaMKII activity to produce CEDE. CEDE is a process that involves exocytosis of smooth endoplasmic reticulum/trans-Golgi network (SER/ TGN)-like organelles in dendrites (Maletic-Savatic and Malinow, 1998) . TGN in cultured neurons is associated with microtubules, because treatment with nocodazole induces the scattering of its vesicles (Lowenstein et al., 1994) . One of the possible mechanisms of CaMKII action in CEDE is the phosphorylation of Figure 4 . Recombinant ␣CaMKII renders immature neurons competent to show CEDE. A, Neurons (7 DIV) loaded overnight with FM1-43 were uninfected (top) or were infected with ␤GALVV (middle) or CaMKIIVV (bottom). A23187 (1 M for 1 min) evoked no significant exocytosis in uninfected and ␤GALVV-infected neurons but produced significant exocytosis in C aM K IIV V-infected neurons. Scale bar, 10 m. B, Quantitative analysis of CEDE in control and infected developing neurons (age is indicated). The following number of cultures was analyzed for each experiment: 5/6 DIV, control n ϭ 12, ␤GALVV n ϭ 7, CaMKIIVV n ϭ 8; 7/8 DI V, control n ϭ 15, ␤GALVV n ϭ 8, CaMKIIVV n ϭ 9; 9 DIV, control n ϭ 8, ␤GALVV n ϭ 5, CaMKIIVV n ϭ 5. *p Ͻ 0.05; **p Ͻ 0.01. At no age was CEDE significantly different in ␤GALVV and uninfected neurons. microtubule-associated proteins (M APs), which are known to be CaMK II substrates (Braun and Schulman, 1995) . Phosphorylation of M APs by C aM K II has been proposed as the mechanism of dendritic extension (Diez-Guerra and Avila, 1995) , and this process could involve exocytosis like CEDE. Thus, microtubules could act as docking sites for vesicles and proteins, some of which would be C aM K II targets. Alternatively, microtubules could be necessary to deliver vesicles to exocytotic sites, at which point CaMK II could facilitate exocytosis by phosphorylating constituents of the exocytotic machinery.
CEDE and LTP
A number of studies indicate that postsynaptic C aM K II activity is necessary and sufficient for LTP, a form of activity-dependent synaptic plasticity observed in hippocampal neurons (Malenka et al., 1989; Malinow et al., 1989; Silva et al., 1992; Pettit et al., 1994; Lledo et al., 1995) . Could CEDE play a role in LTP? It has been reported recently that postsynaptic exocytosis is required for LTP (Lledo et al., 1998) . During LTP induction localized calcium entry might trigger the insertion of glutamate receptors (stored in intracellular compartments or perisynaptic regions; Hampson et al., 1992; Baude et al., 1995) into synapses by a CEDE-like process. This would change the postsynaptic site functionally so that it would produce larger responses to synaptically released transmitter. Interestingly, a recent study found that, during LTP induction, CaMKII activation and AMPA receptor phosphorylation (Barria et al., 1997) occur with a time course that closely parallels the time course we have found for CEDE (MaleticSavatic and Malinow, 1998) . We have shown that CEDE is associated spatially with the spine-like structures in cultured hippocampal neurons and that it involves the exocytosis of SER/ TGN-derived organelles (Maletic-Savatic and Malinow, 1998) . With SER and smooth vesicles present in the spine apparatus (Spacek and Harris, 1997) and CaMKII, an abundant protein in the postsynaptic density , all of the machinery necessary for CEDE is likely to be present in a spine, the site where synaptic plasticity occurs.
Although our studies did not demonstrate the relation between CEDE and synaptic plasticity directly, our data are quite suggestive that these phenomena might be associated. It is well established that increases in intracellular levels of Ca 2ϩ at synaptic regions as well as the activation of C aM K II play central roles in triggering LTP. Similarly, C a 2ϩ elevations and C aM K II activity trigger and mediate CEDE of organelles close to synapses. Therefore, these findings are consistent with the view that CEDE plays a role in LTP.
A variety of model mechanisms has been proposed to explain the cellular changes that underlie synaptic plasticity. Some models suggest that an increase in synaptic strength can occur without any obvious change in synaptic structure, whereas others propose that synaptic plasticity is associated with the structural change at the synapse. On the basis of our results, we propose the following model of synaptic plasticity mechanism that might change the postsynaptic site both f unctionally and structurally (Fig. 6) . SER/ TGN-like organelles that are present in dendrites and perisynaptic sites are attached to microtubules. During repetitive synaptic transmission C a 2ϩ enters through NMDA receptors and activates C aM K II. Possibly by phosphorylation of some MAPs, this leads to regulated f usion of SER / TGN-derived organelles with the dendritic plasma membrane. This f usion might expose new receptors at the surface of the postsynaptic cell, release factors that might affect presynaptic f unction, or provide more membrane for the growth of the synapses. Figure 6 . CEDE as a possible mechanism of synaptic plasticity. C a 2ϩ -induced activation of ␣CaMKII leads to the regulated f usion of perisynaptic SER/TGN-derived organelles with the dendritic plasma membrane. This fusion could ( A) expose new receptors at the surface of the postsynaptic cell, ( B) release factors that might affect presynaptic f unction, or ( C) provide more membrane for the growth of synapses.
